Ascentage Pharma Group International (AAPG) Non-Current Assets: 2023-2024

Historic Non-Current Assets for Ascentage Pharma Group International (AAPG) over the last 2 years, with Dec 2024 value amounting to $156.7 million.

  • Ascentage Pharma Group International's Non-Current Assets was N/A to $157.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $157.3 million, marking a year-over-year change of. This contributed to the annual value of $156.7 million for FY2024, which is 4.23% down from last year.
  • According to the latest figures from FY2024, Ascentage Pharma Group International's Non-Current Assets is $156.7 million, which was down 4.23% from $163.6 million recorded in FY2023.
  • Over the past 5 years, Ascentage Pharma Group International's Non-Current Assets peaked at $163.6 million during FY2023, and registered a low of $156.7 million during FY2024.
  • Moreover, its 2-year median value for Non-Current Assets was $160.1 million (2024), whereas its average is $160.1 million.
  • Data for Ascentage Pharma Group International's Non-Current Assets shows a maximum YoY dropped of 4.23% (in 2024) over the last 5 years.
  • Over the past 2 years, Ascentage Pharma Group International's Non-Current Assets (Yearly) stood at $163.6 million in 2023, then fell by 4.23% to $156.7 million in 2024.